HFS
BIIB icon

Hantz Financial Services’s Biogen BIIB Stock Holding History

Hantz Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Buy
2,157
+321
+17% +$59.1K 0.01% 736
2025
Q4 		$323K Buy
1,836
+200
+12% +$32.7K ﹤0.01% 697
2025
Q3 		$229K Buy
1,636
+453
+38% +$61.2K ﹤0.01% 702
2025
Q2 		$149K Buy
1,183
+1,153
+3,843% +$144K ﹤0.01% 668
2025
Q1 		$4K Buy
+30
New +$4.29K ﹤0.01% 1193
2024
Q2 		– Sell
-26
Closed -$6K – 1073
2024
Q1 		$6K Hold
26
– – ﹤0.01% 899
2023
Q4 		$7K Sell
26
-40
-61% -$9.82K ﹤0.01% 859
2023
Q3 		$17K Buy
66
+40
+154% +$10.7K ﹤0.01% 746
2023
Q2 		$7K Hold
26
– – ﹤0.01% 827
2023
Q1 		$7K Hold
26
– – ﹤0.01% 831
2022
Q4 		$7K Hold
26
– – ﹤0.01% 802
2022
Q3 		$7K Hold
26
– – ﹤0.01% 789
2022
Q2 		$5K Sell
26
-3
-10% -$613 ﹤0.01% 837
2022
Q1 		$6K Buy
+29
New +$6.31K ﹤0.01% 855

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hantz Financial Services's BIIB Position: Q1 2026 in Review

Hantz Financial Services increased its Biogen (BIIB) stake by 17% in Q1 2026, buying an estimated $59.1K and bringing the position to 2,157 shares worth $395K. The position accounts for 0.01% of the portfolio, ranked #736.

Hantz Financial Services first reported a position in BIIB in Q1 2022 and has held it in 14 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Hantz Financial Services held 2,157 shares of Biogen worth $395K as of Q1 2026.
  • Hantz Financial Services bought 321 Biogen shares in Q1 2026, an estimated $59.1K.
  • Biogen made up 0.01% of Hantz Financial Services's portfolio in Q1 2026, its #736 holding.
  • Hantz Financial Services first reported a position in Biogen in Q1 2022 and has held it in 14 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.